<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04886245</url>
  </required_header>
  <id_info>
    <org_study_id>PI2019_843_0089</org_study_id>
    <nct_id>NCT04886245</nct_id>
  </id_info>
  <brief_title>Eye-Tracking FP &quot;A Pilot Study of the Quantitative Evaluation of the Attention Paid to Faces With Facial Palsy by the Eye-tracking Technology.</brief_title>
  <acronym>EyeTrackingFP</acronym>
  <official_title>Eye-Tracking FP &quot;A Pilot Study of the Quantitative Evaluation of the Attention Paid to Faces With Facial Palsy by the Eye-tracking Technology.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The facial palsy concerns between 15 and 40 people per 100000 inhabitants. They are of&#xD;
      various etiologies such as infectious, tumoral, traumatic or idiopathic.&#xD;
&#xD;
      It has variable severities with sometimes heavy functional repercussions and different&#xD;
      recovery potentials. The proposed palliative treatments are based on surgery, physiotherapy&#xD;
      and botulinum toxin injections. However, when recovery is incomplete, acceptance is more&#xD;
      difficult, with an impacted quality of life. In this context, patients' expectations and&#xD;
      feelings about their care may become difficult for clinicians to apprehend.&#xD;
&#xD;
      The eye-tracking is widely used in the marketing field, but it also finds medical&#xD;
      applications including head and neck lesions and facial palsy in particular. Published&#xD;
      studies focus on the gaze of photographs, excluding any notion of dynamics and by the&#xD;
      analysis of the gaze of outside observers, ignoring the patient's gaze.The main objective is&#xD;
      to evaluate the attention paid to the facial side with abnormal facial movement by patients&#xD;
      with facial paralysis compared to healthy volunteers.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 6, 2021</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">May 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Variation of facial fixation day number between facial palsy patients and healthy volunteers</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of facial movement abnormality between facial palsy patients and healthy volunteers</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Eye-tracking</condition>
  <condition>Facial Palsy</condition>
  <arm_group>
    <arm_group_label>facial palsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient with peripheral facial palsy, irrespective of grade, whether or not previously treated</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>- Subject without major facial sequelae</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Video sequences</intervention_name>
    <description>videos will be made of each participant, during the realization of 5 movements that are the simple closure of the eyelids, the forced closure of the eyelids, the labial protrusion on the sound [o], the labial protrusion on the sound [pu] and the wide smile uncovering the teeth.&#xD;
Then, a video sequence will be realized thanks to the dedicated software Tobii Pro Lab®.</description>
    <arm_group_label>facial palsy</arm_group_label>
    <arm_group_label>healthy volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  for patient with facial paralysis:&#xD;
&#xD;
          -  Patient with peripheral facial palsy, irrespective of grade, whether or not previously&#xD;
             treated&#xD;
&#xD;
          -  Patient providing written informed consent&#xD;
&#xD;
          -  Patient aged ≥ 18 years&#xD;
&#xD;
          -  Patient affiliated to a social security system&#xD;
&#xD;
          -  for Healthy voluntary subject :&#xD;
&#xD;
          -  Subject without major facial sequelae&#xD;
&#xD;
          -  Subject who provided written informed consent&#xD;
&#xD;
          -  Major subject ≥ 18 years old&#xD;
&#xD;
          -  Subject affiliated to a social security system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  for Patient with facial paralysis:&#xD;
&#xD;
          -  Patient with recent peripheral facial palsy whose total recovery is possible&#xD;
&#xD;
          -  Patient unable to provide written informed consent&#xD;
&#xD;
          -  Patient with difficulties to follow instructions and especially to stand in front of a&#xD;
             computer screen&#xD;
&#xD;
          -  Minor patient &lt;18 years&#xD;
&#xD;
          -  Patient under guardianship or curators or judicial safeguard&#xD;
&#xD;
          -  for Healthy voluntary subject :&#xD;
&#xD;
          -  Subject with major facial sequelae&#xD;
&#xD;
          -  Subject not able to provide written informed consent&#xD;
&#xD;
          -  Subject presenting difficulties in following instructions and in particular in&#xD;
             standing still in front of a computer screen&#xD;
&#xD;
          -  Minor subject &lt; 18 years old&#xD;
&#xD;
          -  Subject under guardianship or curators or judicial safeguard&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stéphanie DAKPE, PR</last_name>
    <phone>03.22.08.90.50</phone>
    <email>dakpe.stephanie@chu-amiens.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sylvie TESTELIN</last_name>
    <phone>03.22.08.90.50</phone>
    <email>testelin.sylvie@chu-amiens.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80480</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphanie DAKPE, Pr</last_name>
      <phone>03.22.08.90.50</phone>
      <email>dakpe.stephanie@chu-amiens.fr</email>
    </contact>
    <contact_backup>
      <last_name>Sylvie Testellin, Pr</last_name>
      <phone>03 22 08 90 50</phone>
      <email>testelin.sylvie@chu-amiens.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Bernard DEVAUCHELLE, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luc VANDROMME, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Federica CILIA, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 7, 2021</study_first_submitted>
  <study_first_submitted_qc>May 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2021</study_first_posted>
  <last_update_submitted>May 12, 2021</last_update_submitted>
  <last_update_submitted_qc>May 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>facial mimics</keyword>
  <keyword>eye-tracking</keyword>
  <keyword>Facial Palsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bell Palsy</mesh_term>
    <mesh_term>Facial Paralysis</mesh_term>
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Facies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

